The Longevity Suite
Amount undisclosed
Funding date
Valuation / Funding
No funding history available
Funding data has not been imported for this company yet
Current Valuation Metrics
The Longevity Suite is currently valued at N/A as of October 1, 2024. The company has raised a total of $16.6M in funding.
Investment Perspective
The Longevity Suite's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.
What is The Longevity Suite Worth in 2025?
As of 2025, The Longevity Suite is valued at N/A, based on the company's PE Growth/Expansion funding round in October 1, 2024. This valuation positions The Longevity Suite as one of the leading private companies in the sector.
The Longevity Suite Valuation History
The Longevity Suite's funding history demonstrates steady growth and investor confidence.
How The Longevity Suite Valuation is Determined
Private company valuations like The Longevity Suite's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:
- Revenue growth and financial performance
- Market opportunity and total addressable market (TAM)
- Competitive positioning and market share
- Management team strength and execution capability
- Technology and intellectual property
- Industry trends and investor sentiment
The Longevity Suite Valuation FAQs
Is The Longevity Suite profitable?
The Longevity Suite has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.
How does The Longevity Suite's valuation compare to competitors?
The Longevity Suite is valued at N/A, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.
When will The Longevity Suite IPO?
The Longevity Suite has not announced plans for an initial public offering. Until an IPO, investors can access The Longevity Suite shares through secondary market platforms.